Logos Global Management’s Immunocore IMCR Stock Holding History

Logos Global Management’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.1M	Sell	600,000 -900,000	-60%	-$26.6M	0.82%	37
2026 Q1	$45.2M	Buy	1,500,000 +650,000	+76%	+$21M	2.26%	12
2025 Q4	$29.5M	Hold	850,000	–	–	1.78%	20
2025 Q3	$30.9M	Buy	850,000 +275,000	+48%	+$9.34M	2.77%	13
2025 Q2	$18M	Buy	+575,000	New	+$17.9M	2%	18
2024 Q2	–	Sell	-900,000	Closed	-$58.5M	–	65
2024 Q1	$58.5M	Buy	900,000 +500,000	+125%	+$34.3M	4.73%	4
2023 Q4	$27.3M	Sell	400,000 -50,000	-11%	-$2.6M	2.55%	14
2023 Q3	$23.4M	Sell	450,000 -50,000	-10%	-$2.96M	3.12%	11
2023 Q2	$30M	Hold	500,000	–	–	4.08%	7
2023 Q1	$24.7M	Hold	500,000	–	–	3.54%	9
2022 Q4	$28.5M	Buy	500,000 +150,000	+43%	+$8.44M	3.34%	12
2022 Q3	$16.4M	Buy	+350,000	New	+$16.7M	2.02%	18

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Logos Global Management's IMCR Position: Q2 2026 in Review

Logos Global Management reduced its Immunocore (IMCR) stake by 60% in Q2 2026, selling an estimated $26.6M and leaving 600,000 shares worth $19.1M. The position accounts for 0.82% of the portfolio, ranked #37.

Logos Global Management first reported a position in IMCR in Q3 2022 and has held it in 12 quarters since. The position peaked at $58.5M in Q1 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Logos Global Management held 600,000 shares of Immunocore worth $19.1M as of Q2 2026.
Logos Global Management sold 900,000 Immunocore shares in Q2 2026, an estimated $26.6M.
Immunocore made up 0.82% of Logos Global Management's portfolio in Q2 2026, its #37 holding.
Logos Global Management first reported a position in Immunocore in Q3 2022 and has held it in 12 quarters since.
Logos Global Management's Immunocore position peaked at $58.5M in Q1 2024.
136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Logos Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.